-Advertisement-
-Advertisement-
General

Deuruxolitinib significantly improves scalp hair regrowth in alopecia areata
Deuruxolitinib was found to significantly improve scalp hair regrowth in alopecia areata, according to data from its Phase 3 clinical trial, THRIVE-AA2, presented at the American Academy of Dermatology's (AAD) 2023 Annual Meeting Late Breaking News Session. The primary efficacy endpoint of the trial was the percentage of patients achieving...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
Quizzes
-Advertisement-
Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 MedJournal 360® is a trademark of International Healthcare Media, LLC. All rights Reserved